Zalcenstein A - Search Results

1

Transactivation of the EGR1 gene contributes to mutant p53 gain of function.

Weisz L, Zalcenstein A, Stambolsky P, Cohen Y, Goldfinger N, Oren M, Rotter V. Weisz L, et al. Among authors: zalcenstein a. Cancer Res. 2004 Nov 15;64(22):8318-27. doi: 10.1158/0008-5472.CAN-04-1145. Cancer Res. 2004. Retraction in: Cancer Res. 2019 Apr 15;79(8):2085. doi: 10.1158/0008-5472.CAN-19-0560 PMID: 15548700 Retracted.

2

Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutants.

Zalcenstein A, Stambolsky P, Weisz L, Müller M, Wallach D, Goncharov TM, Krammer PH, Rotter V, Oren M. Zalcenstein A, et al. Oncogene. 2003 Aug 28;22(36):5667-76. doi: 10.1038/sj.onc.1206724. Oncogene. 2003. PMID: 12944915

3

Repression of the MSP/MST-1 gene contributes to the antiapoptotic gain of function of mutant p53.

Zalcenstein A, Weisz L, Stambolsky P, Bar J, Rotter V, Oren M. Zalcenstein A, et al. Oncogene. 2006 Jan 19;25(3):359-69. doi: 10.1038/sj.onc.1209061. Oncogene. 2006. PMID: 16170349

4

Retraction: Transactivation of the EGR1 Gene Contributes to Mutant p53 Gain of Function.

Weisz L, Zalcenstein A, Stambolsky P, Cohen Y, Goldfinger N, Oren M, Rotter V. Weisz L, et al. Among authors: zalcenstein a. Cancer Res. 2019 Apr 15;79(8):2085. doi: 10.1158/0008-5472.CAN-19-0560. Cancer Res. 2019. PMID: 30987981 No abstract available.

5

The c-fos proto-oncogene is a target for transactivation by the p53 tumor suppressor.

Elkeles A, Juven-Gershon T, Israeli D, Wilder S, Zalcenstein A, Oren M. Elkeles A, et al. Among authors: zalcenstein a. Mol Cell Biol. 1999 Apr;19(4):2594-600. doi: 10.1128/MCB.19.4.2594. Mol Cell Biol. 1999. PMID: 10082525 Free PMC article.

6

Nitric oxide promotes p53 nuclear retention and sensitizes neuroblastoma cells to apoptosis by ionizing radiation.

Wang X, Zalcenstein A, Oren M. Wang X, et al. Among authors: zalcenstein a. Cell Death Differ. 2003 Apr;10(4):468-76. doi: 10.1038/sj.cdd.4401181. Cell Death Differ. 2003. PMID: 12719724

7

The PI3K inhibitor LY294002 prevents p53 induction by DNA damage and attenuates chemotherapy-induced apoptosis.

Bar J, Lukaschuk N, Zalcenstein A, Wilder S, Seger R, Oren M. Bar J, et al. Among authors: zalcenstein a. Cell Death Differ. 2005 Dec;12(12):1578-87. doi: 10.1038/sj.cdd.4401677. Epub 2005 Jun 3. Cell Death Differ. 2005. PMID: 15933740

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters